The global oral syringes market size was valued at USD 630.7 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 4.2% from 2020 to 2027. There is an increase in demand for syringes owing to the rising pediatric population, easy usability, and increasing prevalence of chronic diseases in the geriatric population. In addition, the rising number of surgical procedures in the pediatric and geriatric population is also expected to propel market growth over the forecast period. Medication errors in the pediatric population are also expected to drive market growth. According to the article published in U.S. Pharmacist in 2019, approximately 200,000 medication errors are reported to the U.S. poison control centers every year and about 30.0% of cases are related to children.
Unlike most drugs for adults, children's medications are often liquid and administration of liquid medication by cups and spoons leads to serious errors. To reduce the incidence of medication errors in children, most of the healthcare agencies are promoting the use of oral syringes worldwide. For instance, the Institute for Safe Use of Medications (ISMP) publishes periodical newsletters and educational programs to increase the awareness of oral syringes in Spain.
Furthermore, increasing incidence of cancer in the children is anticipated to drive the market over the forecast period. According to the WHO in 2018, approximately 300,000 children are diagnosed with cancer annually. Also, oral syringes can’t be reused in cancer treatment. This is expected to accelerate market growth over the forecast period.
Key companies are also introducing technologically advanced oral syringes to strengthen their portfolio in the industry. For instance, BD has improved its product line to maintain market share in the industry.
Clear oral syringes held the largest market share of over 60.0% in 2019 owing to its better viewing of medication and graduation markings. In addition, the segment is anticipated to witness higher growth over the forecast period owing to increasing preference in higher oral dose medication. For instance, clear oral syringes preferred by the physician or nurses for the administration of a dose larger than 10 ml.
The reusable oral syringes segment held the largest market share 50.9% in 2019 owing to no risk of infections and any harmful diseases transfer due to oral route administration. In addition, affordability is an important factor driving the segment in the oral syringes market.
The disposable oral syringes segment is anticipated to witness the fastest growth rate of 4.3% over the forecast period owing to the increase in the prevalence of cancer in the pediatric and geriatric population. Disposable oral syringes are mostly used with chemotherapy.
The hospital segment held largest market share of over 50.0% in 2019 owing to the increasing trend of hospitalization worldwide. In addition, high awareness among the physicians and nursing staff at hospital settings is contributing to the larger market share of the segment.
The home care settings segment is anticipated to witness the fastest growth over the forecast period owing to the increasing adoptability of oral syringes in homecare settings. Due to the lower medication errors, most of the patients prefer oral syringes over the cups and droppers in homecare settings. This is anticipated to drive the segment over the forecast period.
North America accounted for the highest market share of over 30.0% in 2019 owing to the advanced healthcare system and the growing prevalence of chronic diseases in the region. In addition, the presence of major players in the region contributed to market growth. Prominent players operating the region include BD, Cardinal Health, and B. Braun Melsungen AG.
In Asia Pacific, the market is anticipated to witness the fastest growth rate over the forecast period. Increasing the pediatric and geriatric population is anticipated to increase the demand for oral syringes in the region. In addition, increasing awareness about safe oral dose administration in children is boosting market growth over the forecast period.
Mergers and acquisition and new product development are the key strategies adopted by the market players. Some of the prominent players in the oral syringes market include:
Becton
Dickinson and Company
Braun Melsungen AG
Medtronic
Amcor Limited
Smiths Medical
NIPRO Corporation
Gerresheimer AG
Terumo Corporation
Report Attribute |
Details |
Market size value in 2020 |
USD 651.1 million |
Revenue forecast in 2027 |
USD 868.6 million |
Growth rate |
CAGR of 4.2% from 2020 to 2027 |
Base year for estimation |
2019 |
Historical data |
2016 - 2018 |
Forecast period |
2020 - 2027 |
Quantitative units |
Revenue in USD million and CAGR from 2020 to 2027 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product type, usage, end use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Netherlands; Belgium; Switzerland; Russia; Sweden; China; India; Japan; China; Australia; South Korea; Malaysia; Indonesia; Singapore; Philippines; Thailand; Mexico; Brazil; Argentina; Colombia; Chile; South Africa; Saudi Arabia; UAE; Israel; Egypt |
Key companies profiled |
Becton; Dickinson and Company; Braun Melsungen AG; Medtronic; Amcor Limited; Smiths Medical; NIPRO Corporation; Gerresheimer AG; Terumo Corporation |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global oral syringes market report on the basis of product type, usage, end use, and region:
Product Type Outlook (Revenue, USD Million, 2016 - 2027)
Colorful Oral Syringes
Clear Oral Syringes
Usage Outlook (Revenue, USD Million, 2016 - 2027)
Disposable Oral Syringes
Reusable Oral Syringes
End-use Outlook (Revenue, USD Million, 2016 - 2027)
Hospitals
Clinics
Homecare Settings
Regional Outlook (Revenue, USD Million, 2016 - 2027)
North America
The U.S.
Canada
Europe
The U.K.
Germany
France
Spain
Italy
Netherlands
Belgium
Switzerland
Russia
Sweden
Asia Pacific
India
Japan
China
Australia
South Korea
Malaysia
Indonesia
Singapore
Philippines
Thailand
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Middle East & Africa
South Africa
Saudi Arabia
UAE
Israel
Egypt
b. The global oral syringes market size was estimated at USD 630.7 million in 2019 and is expected to reach USD 651.1 million in 2020.
b. The global oral syringes market is expected to grow at a compound annual growth rate of 4.2% from 2020 to 2027 to reach USD 868.6 million by 2027.
b. North America dominated the oral syringes market with a share of 33.3% in 2019. This is attributable to the advanced healthcare system and the growing prevalence of chronic diseases in the country.
b. Some key players operating in the oral syringes market include Becton, Dickinson and Company; Braun Melsungen AG, Medtronic, Amcor Limited, Smiths Medical, NIPRO Corporation, Gerresheimer AG, and Terumo Corporation.
b. Key factors that are driving the market growth include rising pediatric population, easy usability, and increasing prevalence of chronic diseases in the geriatric population.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."